About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 8,045 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 8,045 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6461-6480 of 8,045 trials

Not yet recruitingQL1706/Bevacizumab ± Chemotherapy in Post-ICI Non-Squamous NSCLCThe goal of this clinical trial is to evaluate QL1706 plus bevacizumab with or without chemotherapy in patients with PD-L1-negative, locally advanced or metastatic non-squamous…NCT07134413 RecruitingA Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsThis study will test the safety of a drug called PF-08046054/SGN-PDL1V alone and with pembrolizumab in participants with solid tumors.NCT05208762·Birmingham, Alabama and 61 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingNintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer PatientsThe purpose of this study is to evaluate the efficacy and safety of Nintedanib with EGFR-TKI in participants with advanced EGFR-TKI-resistant non-small cell lung cancerNCT06071013·Taichung

CompletedStudy of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)The purpose of this study is to evaluate safety and tolerance of M2ES with TC regimen in advanced NSCLC.NCT01099124·Tianjin

Enrolling by invitationA Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) ProductsThis protocol is to ensure consistent long-term follow-up for delayed safety events in participants who received A2 Bio gene therapy (GT) products.NCT06885424·Gilbert, Arizona and 2 others

CompletedEndobronchial Ultrasound Guided Transbronchial Aspiration (EBUS-TBNA) in Non Small Cell Lung Cancer (NSCLC) in a Tuberculosis-endemic CountryIn lung cancer with enlarged or non-enlarged mediastinal lymph nodes, contrast-enhanced computed tomography (CT) and Positron emission tomography (PET) scan frequently show…NCT01156623·Taipei, Taipei

UnknownA Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial LesionsThis research study is studying a drug as a possible treatment for ALK-positive or ROS1-positive non-small cell lung cancer (NSCLC).NCT02927340·Boston, Massachusetts

Active not recruitingA Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C MutationA Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS G12C mutation to determine the maximum tolerated dose and recommended Phase II dose of…NCT05485974·Encinitas, California and 13 others

Not yet recruitingSP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLCSingle-POrt Robotic-assisted thoracic surgery versus single-port video-assisted Thoracic Surgery major pulmonary resection for patients with non-small cell lung cancer (SPORTS…NCT06202690

RecruitingAK129 Combination Therapy for Advanced Solid TumorsThis is an open, multicenter phase Ib/II clinical study.NCT06943820·Shenyang, Liaoning

CompletedAPRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung CancerThis study will compare the anti-tumor efficacy of apricoxib and erlotinib with placebo and erlotinib as measured by time to disease progression to test the hypothesis that down…NCT00652340·Tucson, Arizona and 46 others

Active not recruitingActivity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC PatientsThis study includes patients diagnosed with a metastatic non small cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK) translocation.NCT04127110·Brussels and 25 others

CompletedPhase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung CancerCombining nimotuzumab to gefitinib may not only potentiate cellular cytotoxicity, but may also assist in overcoming inherent or acquired resistance to gefitinib alone.NCT01498562·Seoul

RecruitingA Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung CancerHS-10365 is a small molecular, oral potent, selective RET inhibitor.NCT06147570·Shanghai, Shanghai Municipality

CompletedStudy of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior TherapyThe purpose of this study is to establish the objective response rate (complete response + partial response), following treatment with Alimta plus VELCADE, Alimta alone, or…NCT00343720·Haine-Saint-Paul

CompletedTissue Microarrays (TMAs) Construction in Lung Cancer SamplesConstruction of a large cohort of lung cancer patients to evaluate the Prognostic and Predictive Significance of the molecular biomarkers Epidermal growth factor receptor (EGFR)…NCT03136523·Athens

CompletedA Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1The main purpose of this study is to examine the safety and tolerability of CDX-1401 when given in combination with an immune stimulant (resiquimod) to patients with advanced…NCT00948961·New Haven, Connecticut and 6 others

CompletedFeasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer PatientsRATIONALE: Continued smoking after a cancer diagnosis has important health consequences beyond the risks associated with smoking in the general population.NCT01434342·Winston-Salem, North Carolina

CompletedThe Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With AfatinibThis is an observational, non-interventional, single-country, multi center, retrospective cohort study, based on real world data collection, of patients with locally advanced or…NCT04640870

CompletedKeynatinib in Treated Patients With NSCLC and Brain MetastasesThe purpose of this study is to evaluate the safety and efficacy of Keynatinib capsules in patients with advanced non-small cell lung cancer (NSCLC) with brain metastasis or…NCT04824079·Beijing, Beijing Municipality and 4 others

PreviousPage 324 of 403Next